AE Wealth Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,597
| Closed | -$1.25M | – | 1799 |
|
|
2023
Q4 | $1.25M | Buy |
6,597
+24
| +0.4% | +$4.56K | 0.01% | 1071 |
|
|
2023
Q3 | $972K | Buy |
6,573
+1,738
| +36% | +$257K | 0.01% | 1108 |
|
|
2023
Q2 | $1.06M | Buy |
4,835
+192
| +4% | +$42K | 0.01% | 1072 |
|
|
2023
Q1 | $1.02M | Buy |
4,643
+147
| +3% | +$32.2K | 0.01% | 1033 |
|
|
2022
Q4 | $936K | Buy |
4,496
+522
| +13% | +$109K | 0.01% | 1013 |
|
|
2022
Q3 | $868K | Sell |
3,974
-408
| -9% | -$89.1K | 0.01% | 996 |
|
|
2022
Q2 | $919K | Buy |
4,382
+797
| +22% | +$167K | 0.01% | 914 |
|
|
2022
Q1 | $869K | Buy |
3,585
+30
| +0.8% | +$7.27K | 0.01% | 959 |
|
|
2021
Q4 | $926K | Buy |
3,555
+1,646
| +86% | +$429K | 0.01% | 953 |
|
|
2021
Q3 | $503K | Buy |
1,909
+92
| +5% | +$24.2K | ﹤0.01% | 1167 |
|
|
2021
Q2 | $448K | Sell |
1,817
-553
| -23% | -$136K | ﹤0.01% | 1175 |
|
|
2021
Q1 | $460K | Buy |
2,370
+87
| +4% | +$16.9K | ﹤0.01% | 1058 |
|
|
2020
Q4 | $485K | Buy |
2,283
+310
| +16% | +$65.9K | 0.01% | 973 |
|
|
2020
Q3 | $338K | Buy |
1,973
+289
| +17% | +$49.5K | ﹤0.01% | 996 |
|
|
2020
Q2 | $323K | Buy |
1,684
+202
| +14% | +$38.7K | 0.01% | 995 |
|
|
2020
Q1 | $218K | Sell |
1,482
-1,280
| -46% | -$188K | 0.01% | 976 |
|
|
2019
Q4 | $428K | Buy |
2,762
+470
| +21% | +$72.8K | 0.01% | 785 |
|
|
2019
Q3 | $310K | Buy |
+2,292
| New | +$310K | 0.01% | 772 |
|